Hilton Beats Expectations on Heavy Demand for U.S. Vacations

(Bloomberg) — Hilton Worldwide Holdings Inc. reported better-than-expected results for the second quarter, as travelers made up for lost vacations.

  • The company reported adjusted earnings per share of 56 cents, according to a statement Thursday, beating the average analyst estimate of 39 cents. Its shares surged as much as 4.2%, the biggest intraday jump in more than five months.

Key Insights

  • Leisure travel surged in the U.S., which accounts for the largest share of Hilton’s revenue, helping push occupancy rates and room prices higher. Strong demand from vacationers offset sluggish corporate travel, helping U.S. hotels match pre-pandemic performance in recent weeks.
  • Revenue per available room, or Revpar, more than tripled from a year earlier, benefiting from a comparison to a period when global travel was locked down. Revpar was down 62% from the second quarter of 2019, before Covid-19 roiled global travel.
  • U.S. Room demand continued to improve in July even as Covid-cases spiked, Chief Executive Officer Christopher Nassetta said on a conference call with investors. With occupancy rates rising, labor availability remains a key issue, Nassetta said.
  • Still, the spread of the highly transmissible delta variant is threatening the travel rebound. Hilton is seeing a slower recovery in parts of the world with lower vaccination rates. Occupancy rates were 64% in the U.S., compared to 56% in Asia and 32% in Europe.

Market Reaction

  • Hilton shares jumped to $134.99 on Thursday in New York. The stock had gained 16% this year through Wednesday’s close, compared with a 2% gain for the Bloomberg Americas Lodging Index.

(Updates share price and adds CEO comments from earnings call.)

More stories like this are available on bloomberg.com

©2021 Bloomberg L.P.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Mission
Why Is the Mission of Benchmark So Important
December 23, 2025

As pharmaceutical innovation accelerates, the margin for error narrows, making quality assurance not just a regulatory necessity but a public good. Benchmark’s mission sits at the intersection of progress and protection—helping manufacturers stay aligned with FDA standards so life-saving therapies reach patients faster and safer. By keeping cleanrooms compliant and companies out of trouble, Benchmark…

Read More
Benchmark
What Is It Like for You to Be Part of the Benchmark Products Teams Now
December 23, 2025

Being part of the Benchmark Products team today means working at the intersection of precision manufacturing and deeply human collaboration, especially in the high-stakes world of cleanroom and sterility assurance solutions. As the organization grows, employees describe a culture that still feels familial—one where clear communication, personal accountability, and genuine care for customers drive…

Read More
Cleaning
Do Your Friends Ever Ask You For Cleaning Tips
December 23, 2025

In a media landscape increasingly shaped by privacy constraints, data clean rooms have emerged as a quiet but powerful way for brands to collaborate without exposing sensitive information, even if, as Will Sepsis quips, some partners would still prefer that “ignorance is bliss.” That tension—between curiosity and caution—captures the moment we’re in, where understanding…

Read More
Clean
Do You Friends Ask You For Cleaning Methods or Clean Their Home
December 23, 2025

At Benchmark Products, where cleanroom precision is part of everyday work, professionals often discover that specialized knowledge doesn’t always translate neatly into casual conversations—especially when friends jokingly wonder if you’ll critique their homes or turn them into germaphobes. The reality is that cleanroom science is about controlled environments and risk mitigation at an industrial scale,…

Read More